Atom | Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional)

Due Dates: May 9, 2025 (AIDS) | September 9, 2025 (AIDS) | January 9, 2026 (AIDS)

Funding Amounts: Up to $275,000 in direct costs over 2 years; no more than $200,000 in any single year.

Summary: Supports innovative research to optimize HIV prevention and care, with a focus on behavioral, social science, and intervention development aligned with NIMH AIDS Research priorities.

Key Information: Clinical trials are optional; foreign and domestic organizations are eligible; limited submission applies.

Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional)

Sign in to see full grant listing